In a supervised setting, the provider can decide when to continue, when to pause, and how to support maintenance once the goal weight or a healthier range is reached
McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlavek J, Bohm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukat A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, OMeara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjostrand M, Langkilde AM
MicroBiome Restore: The Filler-Free 26-Strain Synbiotic 15 billion CFU per serving
Clinical Eligibility (The BMI Rule) According to FDA and ADA 2026 standards, you should consider Semaglutide if you meet one of these two criteria: BMI of 30 or greater: Classified as obesity